What is the example order for opioid rotation from morphine to fentanyl?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Opioid Rotation from Morphine to Fentanyl: Step-by-Step Guide

To convert from morphine to transdermal fentanyl, follow a systematic two-step process that calculates the 24-hour morphine requirement first, then selects the appropriate fentanyl patch dose based on established conversion tables. 1

Step-by-Step Conversion Process

Step 1: Calculate 24-hour morphine requirement

  • Calculate the total daily morphine dose the patient is currently receiving 1
  • For IV morphine, multiply the hourly rate by 24 to get the total daily dose 1
  • For oral morphine, add up all doses taken in a 24-hour period 1

Step 2: Select appropriate fentanyl patch dose

  • Using the conversion table, match the 24-hour morphine dose to the corresponding fentanyl patch strength 1
  • For morphine doses between 60-134 mg/day oral (or 20-44 mg/day IV/SubQ), select 25 mcg/h fentanyl patch 1, 2
  • For morphine doses between 135-224 mg/day oral (or 45-74 mg/day IV/SubQ), select 50 mcg/h fentanyl patch 1, 2
  • For morphine doses between 225-314 mg/day oral (or 75-104 mg/day IV/SubQ), select 75 mcg/h fentanyl patch 1, 2
  • For morphine doses between 315-404 mg/day oral (or 105-134 mg/day IV/SubQ), select 100 mcg/h fentanyl patch 1, 2

Clinical Example

For a patient taking 60 mg oral morphine every 12 hours (120 mg/day total):

  1. Calculate total daily morphine: 60 mg × 2 = 120 mg/day oral morphine 1
  2. Using the conversion table, 120 mg/day oral morphine corresponds to 50 mcg/h transdermal fentanyl 1

Important Clinical Considerations

  • Always prescribe breakthrough pain medication during the transition period, particularly during the first 8-24 hours when fentanyl levels are still reaching steady state 1
  • The breakthrough medication should be a short-acting opioid, typically 10-15% of the total daily dose 3
  • Fentanyl patches take 12-24 hours to reach therapeutic levels; maintain the previous opioid during this initial period 1, 2
  • After 2-3 days, adjust the patch dose based on the average amount of breakthrough medication required 1
  • Fentanyl patches are typically changed every 72 hours, though some patients may require replacement every 48 hours 1

Cautions and Pitfalls

  • Patches are NOT recommended for unstable pain requiring frequent dose changes 1
  • Use fentanyl patches only in opioid-tolerant patients 2
  • Avoid application of heat (fever, heating pads, electric blankets) as this accelerates fentanyl absorption 1
  • When converting from high doses of morphine or in cachectic patients, consider reducing the calculated fentanyl dose by 30-50% to prevent opioid toxicity 4
  • Overestimating the fentanyl dose when converting from another opioid can result in fatal overdose 2
  • For patients with renal impairment, use extra caution as fentanyl may be safer than morphine but dose reduction may still be necessary 4

Special Situations

  • For continuous parenteral fentanyl infusion to transdermal fentanyl, use a 1:1 ratio (mcg of parenteral fentanyl equals mcg/h of transdermal fentanyl) 1
  • For doses exceeding 100 mcg/h, multiple patches may be used 2
  • In elderly or cachectic patients, consider starting at a lower dose than calculated due to altered pharmacokinetics 4

By following this systematic approach to opioid rotation from morphine to fentanyl, clinicians can maintain effective pain control while minimizing the risk of adverse effects and overdose.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Converting from Hydromorphone to Oxycodone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Opioid rotation from transdermal fentanyl to continuous subcutaneous hydromorphone in a cachectic patient: A case report and review of the literature.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.